Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cochlear function in ears with immunomediated inner ear disorder.

Antonio Quaranta1, Angelo Scaringi, Vincenzo Sallustio

  • 1Department of Ophthalmology and Otorhinolaryngology, ENT Clinic, University of Bari, Italy. otorino1@orl.uniba.it

Acta Oto-Laryngologica. Supplementum
|September 5, 2002
PubMed
Summary

Immunomediated inner ear disorders cause endolymphatic hydrops, leading to hearing loss and cochlear dysfunction. Immunosuppressive treatment can restore hearing and normalize cochlear function, suggesting its utility in monitoring disease progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FEA Simulation of Crimping Pressure Distribution in Titanium and Teflon Stapedotomy Prostheses.

Materials (Basel, Switzerland)·2026
Same author

Integrating GWAS meta-analysis with human brain cell mapping implicates the amygdala and the midbrain in the pathogenesis of tinnitus.

medRxiv : the preprint server for health sciences·2025
Same author

Pragmatic language abilities in children with cochlear implants: a comparison of developmental outcomes with typically hearing peers.

Journal of communication disorders·2025
Same author

Randomised controlled trial to assess the efficiency and effectiveness of remote care compared with in-clinic care for adult cochlear implant recipients in the first 12 months after activation: a protocol of the INSPIRE study.

BMJ open·2025
Same author

Effect of Middle Ear Prosthesis Diameter in Platinotomy and Partial Platinectomy on Hearing Gain: A Finite Element Study.

Materials (Basel, Switzerland)·2025
Same author

Prognostic factors in myringoplasty: a single institution retrospective chart review.

Acta oto-laryngologica·2025

Area of Science:

  • Otolaryngology
  • Immunology
  • Audiology

Background:

  • Immunomediated inner ear disease is a rare condition affecting cochlear function.
  • Acute stages are characterized by endolymphatic hydrops, increased inner ear stiffness, and outer hair cell dysfunction.
  • Patients often present with sensorineural hearing loss and absent otoacoustic emissions.

Purpose of the Study:

  • To evaluate cochlear function in patients with inner ear disorders responsive to immunosuppressive drugs.
  • To assess the impact of endolymphatic hydrops on temporal integration, frequency selectivity, and cochlear mechanics.
  • To determine the efficacy of immunosuppressive treatment in reversing cochlear dysfunction.

Main Methods:

  • Advanced audiological tests assessing temporal integration, frequency selectivity, and cochlear mechanics.

Related Experiment Videos

  • Otoacoustic emission testing.
  • Monitoring of clinical presentation and audiometric curves before and after treatment.
  • Main Results:

    • Inner ear disease induced endolymphatic hydrops, leading to upsloping/flat sensorineural hearing loss and abnormal cochlear function tests.
    • Evoked otoacoustic emissions and distortion-product otoacoustic evoked emissions were absent.
    • Immunosuppressive treatment led to hydrops recovery, hearing normalization, and improved cochlear function.

    Conclusions:

    • Endolymphatic hydrops in the acute phase of immunomediated inner ear disease causes significant cochlear dysfunction.
    • Immunosuppressive therapy is effective in managing the condition and restoring hearing.
    • Testing primary cochlear functions is valuable for monitoring the clinical course of these disorders.